The AHA Guidelines and Scientific Statements Handbook

(ff) #1

The AHA Guidelines and Scientifi c Statements Handbook


adults to live independently [61]. Improved physi-
cal fi tness is also associated with reductions in sub-
maximal heart rate, systolic blood pressure, and
rate-pressure product (RPP), thereby decreasing
myocardial oxygen requirements during moderate-
to-vigorous activities of daily living. Improved
fi tness allows patients with advanced CAD who
ordinarily experience myocardial ischemia during
physical exertion to perform such tasks at a higher
intensity level before reaching an ischemic elec-
trocardiogram or anginal threshold. Furthermore,
improvement in muscular strength after resistance
training also can decrease RPP (and associated myo-
cardial demands) during daily activities, such as car-
rying groceries or lifting moderate to heavy objects
[54]. Improvement in cardiorespiratory endurance
is also associated with a signifi cant reduction in sub-
sequent cardiovascular fatal and nonfatal events
independent of other risk factors [62–65].


Return to work
Although exercise training improves functional
capacity and associated reduction in cardiorespira-
tory symptoms which should enhance a cardiac
patient’s ability to perform most job-related physi-
cal tasks, factors unrelated to physical fi tness appear
to have a greater infl uence on whether a patient
returns to work after a cardiac event [66]. These
factors include socioeconomic and worksite-related
issues, and previous employment status. The educa-
tional and vocational counseling components of CR
programs should further improve the ability of a
patient to return to work.


Effect on CVD prognosis
CR/SP services are benefi cial for patients with estab-
lished CVD. These benefi ts include improved pro-
cesses of care and risk-factor profi les that are closely
linked to subsequent mortality and morbidity.
Pooled data from randomized clinical trials of CR
demonstrate a mortality benefi t of approximately
20% to 25% and a trend towards reduction in non-
fatal recurrent MI [2–11], despite the limitations
inherent in the various analyses, including the
paucity of data for women, older people, ethnic
minorities, and patients who underwent revascular-
ization procedures or who had other types of cardiac
conditions. Major technological and biotechnical
advances in the management of patients with CHD


during the 1990s and early 21st century raise further
questions about the relevance of fi ndings from these
earlier meta-analyses to the independent effects of
contemporary CR/SP on morbidity, mortality, and
other outcome variables. Few data were provided
in these studies on the use of acute thrombolytic
therapy and adjunctive cardioprotective drugs. Fur-
thermore, quality of life was assessed, via a variety
of measures, in only 25% of the clinical trials, and
similar improvement was noted in both the exer-
cise-based rehabilitation and control groups.

Cardioprotective mechanisms
Exercise training, as part of a comprehensive CR/SP
program, has been shown to slow the progression or
partially reduce the severity of coronary atheroscle-
rosis [67–69]. Multiple factors directly or indirectly
appear to contribute to this anti-atherosclerotic
effect including improved endothelial function [70–
73] and anti-infl ammatory effects [74–76] although
these observations require confi rmation, especially
in patients with CAD.
In addition, exercise training and regular physical
activity can result in moderate losses in body weight
and adiposity [77,78], promote decreases in blood
pressure [79,80], improve serum triglycerides and
high-density lipoprotein cholesterol [81–84], and
insulin sensitivity and glucose homeostasis [85].
Along with modest weight reduction, these latter
improvements have been shown to reduce the risk
of type 2 diabetes mellitus in individuals with glucose
intolerance [86,87]. Thus, aerobic exercise can
favorably modify all of the components of the meta-
bolic syndrome [88] and serve as a fi rst-line therapy
to combat this complex constellation of risk factors
for type 2 diabetes mellitus and CVD [89].
Endurance exercise training also has potential
anti-ischemic effects by reducing myocardial isch-
emia in patients with advanced CHD by decreasing
myocardial oxygen demands during physical exer-
tion [48], increasing coronary fl ow by improving
coronary artery compliance or elasticity [90,91] and
endothelium-dependent vasodilatation [76], and
by increasing the luminal area of conduit vessels
through remodeling or arteriogenesis and myocar-
dial capillary density by angiogenesis [92]. Further-
more, in the presence of advanced CAD, exercise
training has been shown to induce ischemic pre-
conditioning of the myocardium and potentially
Free download pdf